Current Assets
Short- term Investments
United Therapeutics Short- term Investments decreased by 35.9% to $874.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 38.5%, from $1.42B to $874.00M. Over 5 years (FY 2020 to FY 2025), Short- term Investments shows an upward trend with a 4.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ3 2025
Last reportedQ1 2026
Metric ID:
current_assets_marketable_securities_currentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.03B | $1.09B | $1.04B | $1.45B | $1.46B | $1.65B | $1.88B | $1.70B | $1.61B | $1.77B | $1.79B | $1.46B | $1.62B | $1.77B | $1.57B | $1.42B | $1.46B | $1.43B | $1.36B | $874.00M |
| QoQ Change | — | +6.5% | -5.1% | +40.4% | +0.4% | +12.9% | +13.9% | -9.5% | -5.2% | +9.7% | +1.1% | -18.5% | +11.0% | +9.7% | -11.4% | -9.5% | +2.4% | -1.9% | -4.5% | -35.9% |
| YoY Change | — | — | — | — | +42.4% | +51.0% | +81.2% | +16.9% | +10.4% | +7.2% | -4.9% | -14.3% | +0.3% | +0.3% | -12.1% | -2.4% | -9.9% | -19.5% | -13.2% | -38.5% |
Range$874.00M – $1.88B
CAGR-3.3%
Avg YoY Growth+5.9%
Median YoY Growth-1.1%
Current Streak3 quarters decline
Short- term Investments at Other Companies
Frequently Asked Questions
- What is United Therapeutics's short- term investments?
- United Therapeutics (UTHR) reported short- term investments of $874.00M in Q1 2026.
- How has United Therapeutics's short- term investments changed year-over-year?
- United Therapeutics's short- term investments decreased by 38.5% year-over-year, from $1.42B to $874.00M.
- What is the long-term trend for United Therapeutics's short- term investments?
- Over 5 years (2020 to 2025), United Therapeutics's short- term investments has grown at a 4.5% compound annual growth rate (CAGR), from $1.10B to $1.36B.